Internalization of Modified Lipids by CD36 and SR-A Leads to Hepatic Inflammation and Lysosomal Cholesterol Storage in Kupffer Cells
Veerle Bieghs(Universitätsklinikum Aachen), Ronit Shiri‐Sverdlov(Maastricht University), Maria Febbraio(University of Alberta), Dieter Lütjohann(University Hospital Bonn), Kristiaan Wouters(Maastricht University), Patrick J. van Gorp(Maastricht University), Tim Hendrikx(Medical University of Vienna), Marten H. Hofker(Maastricht University), Marion J. Gijbels(Maastricht University Medical Centre), Fons Verheyen(Maastricht University), Christoph J. Binder(Medical University of Vienna)
Cited by 121
Related Papers
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2020|1.5k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes
|Nature Genetics|2007|1.1k
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
|Circulation Research|2015|784
A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism
|Journal of Biological Chemistry|1999|764